Clinical Trial Update: Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial investigating Abraxane combined with lapatinib in stage I–III breast cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Lapatinib (Lapatinib)

Snippet

Sponsor: Northwestern University | Conditions: Breast Cancer | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2020-03-06